Skip to main content
Minimalist FootwearExercise and fitnessBehavioralHealthy volunteersHealthmaxxingDeviceBehavioral

What this study is

The goal of this clinical trial is to learn whether different foot-strengthening strategies can improve foot strength, balance, walking ability, and fall-related outcomes in middle-aged and older adults (ages 45-85 years).

The main questions it aims to answer are:

  • Does foot strength change from baseline after an 8-week foot-strengthening intervention?
  • Do balance, gait, and physical function improve following different foot-strengthening approaches?

Researchers will compare minimalist footwear use, a foot exercise program, a foot-strengthening device (ToePro), and no intervention to see if these interventions lead to greater improvements in foot strength, balance, gait, and fall-related outcomes than no intervention.

Participants will:

  • Complete baseline and post-intervention laboratory testing of foot strength, balance, physical function, and walking gait
  • Perform foot strengthening exercises or wear minimalist footwear (if applicable) five days/week for eight weeks
  • Complete daily logs to record intervention compliance

What's being tested

  • Minimalist footwear

    Intervention · DEVICE

    Habitual use of low-cushion, low-structure footwear designed to increase intrinsic foot muscle engagement during daily activities.

  • Foot strengthening exercises

    Intervention · BEHAVIORAL

    Home-based exercises including toe flexion, toe press, and arch-control movements performed several times per week.

  • ToePro foot strengthening device

    Intervention · DEVICE

    A dense foam exercise platform designed to strengthen intrinsic foot muscles through loaded toe press exercises in lengthened muscle positions.

Study details

Official title
Evaluation of a Novel Foot Strengthening Device for Improving Fall Risk, Balance, and Gait With Age
Sponsor
Indiana University
Conditions
Minimalist Footwear · Traditional Foot Exercise Program · Foot Strengthening Device (ToePro) · Control Condition
Enrolling
160 people
Starts
2025-10-21
Est. completion
2027-06-30
Design
Open-label, randomized, parallel groups
Record
View on ClinicalTrials.gov ↗